Protea Biosciences Group, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (21)

Latest Posts

About This Stock More About This Stock
Above The 40 – A Flash Resolution To Bearish Divergence
Article By: Dr. Duru
Monday, November 13, 2017 5:20 AM EDT
It was by the slimmest of margins, but the S&P 500 (SPY) finally ended the last week with a loss. After 8 straight weeks of gains, the index closed the last week with a 0.2% loss as Friday slipped by 0.1%.
In this article: CAT, X, DATA, DXCM, TEVA, ZNGA, IWM, SPY, XLF, APRN, VIX, LOCO, AMC, PRGB, PI Also: AGN
Read
Depomed To Acquire U.S. Rights To NUCYNTA®, NUCYNTA® ER; Amgen Presents First-Line Use Of Vectibix®
Article By: BioMedReports
Friday, January 16, 2015 3:44 AM EDT
Depomed Inc. announced it has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion.
In this article: DEPO, AMGN, DDD, ADXS, ALDX, AMBS, AMED, BSDM, BMRN, CBMG, DVCR, GALE, GB, HTBX, HEB, ISRG, OMED, PMCB, PRGB, RGDX, TGTX, WCUI
Read

PARTNER HEADLINES

Latest Tweets for $PRGB

No tweets yet!